hip fracture
Conditions
Interventions
Intervention group/Control group:transcutaneous electrical acupoint stimulation
Control Group:Sham stimulation (electrodes are applied to the same acupoints without activating the power source)
Sponsors
Shanghai Sixth People's Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 74 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with hip fracture, without other fractures, and scheduled for elective surgical treatment. 2. Age between 60 and 74 years old. 3. American Society of Anesthesiologists (ASA) classification I-III. 4. Body Mass Index (BMI): 18.5-29.9 kg/m². 5. Preoperative ICFS-10 score =24 points. 6. Voluntarily participating in this trial, with the subject or their legal representative signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1.NYHA class III-IV heart function; history of acute myocardial infarction or unstable angina within the past 3 months; malignant arrhythmias such as ventricular tachycardia or ventricular fibrillation; patients with cardiac enlargement and a cardiothoracic ratio >0.7. 2.Severe chronic obstructive pulmonary disease (FEV1.0 45 mmHg; requiring long-term invasive or non-invasive ventilation support; severe interstitial lung disease or severe pulmonary hypertension. 3.Chronic kidney disease (CKD) stages 4-5; uremic stage (requiring hemodialysis or peritoneal dialysis); acute kidney injury (AKI) stage 3; serum creatinine >2 times the upper limit of normal with urine output <0.5 ml/(kg·h) for more than 4 hours. 4.Patients with multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF), or severe hypothyroidism. 5.Long-term use of antiepileptic drugs, antidepressants, or other psychotropic medications. 6.Preoperative hearing, language, or cognitive impairments that hinder effective communication. 7.Preoperative severe sinus bradycardia, sick sinus syndrome, second-degree type II or higher atrioventricular block, or patients with a cardiac pacemaker. 8.Local skin allergy, damage, or infection at the intended stimulation site. 9.Participation in other clinical studies within the past 3 months. 10.Previous exposure to percutaneous electrostimulation therapy at acupuncture points.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early postoperative fatigue incidence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum interleukin-1ß;High-sensitivity C-reactive protein;Serum interleukin-6;Neutrophil to lymphocyte ratio;Postoperative Sleep Quality;Pain score; | — |
Countries
China
Contacts
Public ContactCheng Chen/Zhang Nannan
Shanghai Sixth People's Hospital
Outcome results
None listed